Ovaprene

Ovaprene is an experimental non-hormonal contraception developed by Daré Bioscience that is composed of an intervaginal device that releases ferrous gluconate, ascorbic acid, and glycine.^[1]^[2]^[3]^[4]

References

^ Svoboda, Elizabeth (16 December 2020). "Better birth control". Nature. 588 (7838): S166–S167. Bibcode:2020Natur.588S.166S. doi:10.1038/d41586-020-03532-6. PMID 33328681. S2CID 229302708.
^ Silverwood, Joshua (4 December 2023). "Daré Bioscience launches Phase III hormone-free contraceptive trial". Clinical Trials Arena. Retrieved 5 December 2023.
^ Researchers Investigate Contraceptive Vaginal Ring. Source: Contraceptive Technology Update . Jul2019, Vol. 40 Issue 7, p0-0. 1p. Author(s): AHC MEDIA
^ Mauck, Christine K; Vincent, Kathleen L (4 August 2020). "The postcoital test in the development of new vaginal contraceptives†". Biology of Reproduction. 103 (2): 437–444. doi:10.1093/biolre/ioaa099. PMC 7401356. PMID 32657328.

[1] Svoboda, Elizabeth (16 December 2020). "Better birth control". Nature. 588 (7838): S166–S167. Bibcode:2020Natur.588S.166S. doi:10.1038/d41586-020-03532-6. PMID 33328681. S2CID 229302708.

[2] Silverwood, Joshua (4 December 2023). "Daré Bioscience launches Phase III hormone-free contraceptive trial". Clinical Trials Arena. Retrieved 5 December 2023.

[3] Researchers Investigate Contraceptive Vaginal Ring. Source: Contraceptive Technology Update . Jul2019, Vol. 40 Issue 7, p0-0. 1p. Author(s): AHC MEDIA

[4] Mauck, Christine K; Vincent, Kathleen L (4 August 2020). "The postcoital test in the development of new vaginal contraceptives†". Biology of Reproduction. 103 (2): 437–444. doi:10.1093/biolre/ioaa099. PMC 7401356. PMID 32657328.

[1]

[2]

[3]

[4]